1.A cohort study on cumulative atherogenic index of plasma for predicting the risk of developing new-onset non-alcoholic fatty liver disease in a population of young and middle-aged individuals
Zhenhong GAO ; Qi QI ; Wansong LI ; Xinyu WU ; Quanle HAN ; Lei LI ; Yue JIANG ; Ruojie WU ; Shouling WU ; Kangbo LI
Journal of Clinical Hepatology 2025;41(11):2278-2285
ObjectiveTo investigate the association between cumulative atherogenic index of plasma (cumAIP) and the risk of new-onset nonalcoholic fatty liver disease (NAFLD) in young and middle-aged individuals. MethodsA prospective cohort study was conducted among the young and middle-aged individuals (aged 18 to <60 years) in the Kailuan study cohort who underwent physical examination in Kailuan General Hospital and its 10 affiliated hospitals in June 2006 to October 2010, and after screening based on the inclusion and exclusion criteria, 33 987 individuals were included in the observation cohort. The individuals were divided into Q1, Q2, Q3, and Q4 groups based on the quantiles of cumAIP. The Kaplan-Meier method was used to calculate the cumulative incidence rate of new-onset NAFLD in the four groups, while the log-rank test was used for comparison between groups. A multivariate Cox regression analysis was used to obtain the hazard ratio (HR) and 95% confidence interval (CI) of the risk of new-onset NAFLD in the four groups. A one-way analysis of variance was used for comparison of normally distributed continuous data between multiple groups, and the Kruskal-Wallis H test was used for comparison of non-normally distributed continuous data between multiple groups; the chi-square test was used for comparison of categorical variables between groups. ResultsThe mean follow-up was 10.89±2.54 years, and there were 6 011 cases of new-onset NAFLD, including 995 cases in the Q1 group, 1 366 in the Q2 group, 1661 in the Q3 group, and 1 989 in the Q4 group, with an incidence density of 11.37, 16.02, 19.97, and 24.91 per thousand person-years. The log-rank test showed that there was a significant difference in cumulative incidence rate between the four groups (P<0.001). With the presence or absence of NAFLD as the dependent variable and the quantiles of different exposure levels to cumAIP as the independent variable, the multivariate Cox regression model analysis showed that compared with the Q1 group, the Q2, Q3, and Q4 groups had an HR of 1.30 (95%CI: 1.20 — 1.41), 1.52 (95%CI: 1.41 — 1.65), and 1.79 (95%CI: 1.64 — 1.95), respectively, for new-onset NAFLD, with a Ptrend value of <0.001. With the presence or absence of new-onset NAFLD as the dependent variable and the cumulative exposure to AIP for 0, 2, 4, and 6 years as the independent variable, the Cox regression analysis showed that compared with cumulative exposure to AIP for 0 years, cumulative exposure to AIP for 2, 4, and 6 years had an HR of 1.24 (95%CI: 1.15 — 1.35), 1.51 (95%CI: 1.40 — 1.64), and 1.70 (95%CI: 1.56 — 1.84), respectively, with a Ptrend value of <0.001. A sensitivity analysis was performed after exclusion of the individuals with new-onset NAFLD within 2 years, the individuals who experienced atherosclerotic cardiovascular disease events during follow-up, and the individuals taking antihypertensive, hypoglycemic, and lipid-lowering drugs, and the results were similar to those of the main analysis. Considering the competitive relationship between all-cause death and outcome events, a competing risk analysis of death was performed, which showed that the results of risk analysis were similar to those of the main analysis. ConclusionA high level of cumAIP exposure can increase the risk of new-onset NAFLD in young and middle-aged individuals.
2.Ultrasound Diagnosis and Misdiagnosis Analysis of Accessory Cavitated Uterine Malformation
Fei JI ; Na SU ; Huazhen LIU ; Zijing FU ; Zhenhong QI ; Meng YANG
Medical Journal of Peking Union Medical College Hospital 2024;15(5):1100-1106
To explore the ultrasound characteristics of accessory cavitated uterine malformation (ACUM) and the causes of misdiagnosis, in order to better understand the disease and improve the diagnostic ability of radiologists. We retrospectively collected clinical, pathological and imaging data of ACUM patients who were diagnosed after surgery at Peking Union Medical College Hospital from December2013 to December 2023. Besides, we analyzed ultrasound features of ACUM and the cause of misdiagnosis. A total of 11 patients were included, with a mean age of diagnosis of (27.1±7.4)years. There was a mean interval of (6.1±5.5)years between menarche and onset of dysmenorrhea. Preoperative ultrasound showed that ACUM appeared as solitary lesions located under the insertion of the round ligament, with a mean maximum diameter of (3.0±1.0)cm. Lesions were round or oval (90.9%, 10/11) and not connected to the uterine cavity (100%, 11/11) with clear boundaries (72.7%, 8/11), presenting as regular thick-walled cystic-solid structures. Cystic areas were observed within the mass (100%, 11/11) with a ground-glass-like appearance (90.9%, 10/11) and hyperechoic endometrial lining (90.9%, 10/11). The surrounding of the mass showed hypoechoic or isoechoic areas resembling the muscular layer and circular or semi-circular vascularity was detected around the mass. No adenomyosis or other uterine lesions were found. Analysis of misdiagnosis: Among the 11 ACUM cases, 6 were correctly diagnosed by the initial ultrasound examination, and 5 cases by MRI. Two patients were misdiagnosed as residual horn uterus by MRI, despite ultrasound suggesting ACUM with visible bilateral uterine horns. ACUM exhibits distinct ultrasound characteristics. When young women present with progressive dysmenorrhea and ultrasound reveals a regular cystic-solid mass with thick wall located under the round ligament insertion, ACUM should be considered.
3.Modern Pharmacological Effect of Zhishi Xiebai Guizhitang: A Review
Zhanzhan HE ; Zhen YANG ; Yujie QI ; Xiangyun CHEN ; Ying GENG ; Zhenhong LIU ; Xuguang TAO ; Jing YU ; Kaiyuan ZHANG ; Ce CHU ; Yulu YUAN ; Wenlai WANG ; Hongxia ZHAO
Chinese Journal of Experimental Traditional Medical Formulae 2023;29(6):254-259
Zhishi Xiebai Guizhitang is a classical prescription for the treatment of chest impediment with the method of warming Yang. It is included in the Catalogue of Ancient Classical Prescriptions issued by the National Administration of Traditional Chinese Medicine (First Batch), with the effect of activating Yang, dissipating mass, moving Qi and resolving phlegm. Its main symptoms include chest fullness and pain, or even chest pain radiating to the back, wheezing, coughing, shortness of breath, and Qi reversal from the hypochondrium. In modern traditional Chinese medicine, Zhishi Xiebai Guizhitang is clinically used in the treatment of cardiovascular system, digestive system, respiratory system and other diseases, among which coronary heart disease, unstable angina pectoris, myocardial infarction, sinus bradycardia and other cardiovascular diseases have particularly significant effects. This paper reviewed the pharmacological studies of Zhishi Xiebai Guizhitang in the past 10 years. The results showed that each single medicine and the whole prescription alleviated the above cardiovascular diseases to a certain extent, with the pharmacological effects of improving intravascular environment, myocardial ischemia, myocardial ischemia-reperfusion injury, and myocardial hypoxia, anti-inflammation, plaque stabilisation, etc., and the pharmacological mechanism involved the regulation of relevant active substances in vivo as well as related signaling pathways and ion channels, mainly including thromboxane B2 (TXB2), prostacyclin I2(PGI2) and phosphatidylinositol 3-kinases/protein kinase B/endothelial nitric oxide synthase (PI3K/Akt/eNOS) signaling pathways, and ATP-sensitive potassium channels. In addition, the relationship between the pharmacological effects of some single medicines and transient receptor potential ankyrin 1 (TRPA1) has been reported that TRPA1 is a key to understanding the mechanism of Zhishi Xiebai Guizhitang in treating cardiovascular diseases, which is worth of further study.
4.Ultrasonic differential diagnosis analysis of female urethral diverticulum and vaginal wall cyst
Na SU ; Yonghan WEI ; Zhenhong QI ; He LIU ; Meng YANG
Chinese Journal of Ultrasonography 2022;31(1):56-62
Objective:To explore the clinical and ultrasound image characteristics and differential diagnosis of female urethral diverticulum(UD) and vaginal wall cysts.Methods:A retrospective analysis of the clinical and ultrasound image features of 12 female patients with UD were collected as UD group and 30 patients with vaginal wall cysts confirmed by surgical pathology and clinical follow-up were collected as vaginal wall cysts group in Peking Union Medical College Hospital from January 2017 to May 2021. Ultrasound image characteristics, and the main points of the differential diagnosis of the two were analyzed and summarized.Results:There were no significant differences in the age of the patients and the maximum diameter of the lesions between UD group and vaginal wall cysts group(all P>0.05). Eight cases (66.7%) of female patients with UD had urinary system symptoms, 5 cases (16.7%) of vaginal wall cysts had urinary system symptoms, the difference was statistically significant ( P<0.05); In 10 cases (83.3%) the UD lesions were located in the upper middle and upper pelvic floor, and vaginal wall cyst lesions in 23 cases (76.7%) were located in the lower middle and lower pelvic floor, the difference was statistically significant ( P<0.05). In terms of ultrasound image characteristics, UD lesions were often irregular in shape, surrounding the urethra, with unclear borders, cyst wall thickness >0.1 cm, internal wall not smooth along with calcification, internal visible separation, partly visible to the urethra, and peripheral blood flow signals were abundant. Vaginal wall cysts were mostly round-shaped, not surrounding the urethra, clear borders, thin and smooth walls, less internal partitions, not communication with the urethra, and the peripheral blood flow signals were not abundant. The differences between the two group were statistically significant (all P<0.05). Whether the sound transmission inside the lesion was not statistically significant ( P>0.05). Conclusions:Combined with urinary system symptoms, lesion location, ultrasound characteristics (morphology, whether surrounding the urethra, boundary, cyst wall thickness, inner wall calcification, internal separation, whether it is connected to the urethra, blood flow distribution) can be used to distinguish between UD and vaginal wall cysts, whether the sound transmission inside the lesion cannot be used as the basis for the differential diagnosis of the two.
5.Ultrasound diagnosis of pelvic lipomatosis and misdiagnosis analysis
Tianhong TANG ; Na SU ; Wei SUN ; Sirui LIU ; Ming WANG ; Zhenhong QI ; Jianchu LI ; Meng YANG ; Yuxin JIANG
Chinese Journal of Ultrasonography 2020;29(4):359-363
Objective:To discuss the value of ultrasound in the diagnosis of pelvic lipomatosis and analyze the causes of misdiagnosis.Methods:A retrospective analysis of 68 cases of pelvic lipomatosis confirmed by operation or imaging in Peking Union Medical College Hospital from January 2000 to December 2018 was made to summarize the characteristics of ultrasonic manifestations.Results:Ultrasonographic findings were as follows: 6 cases (8.8%) had increased fat-like hyperecho in pelvic cavity; 60 cases (88.2%) had abnormal bladder; 42 cases (61.7%) had pyelectasis and 24 cases (35.3%) had ureterectasis. Of the 68 cases, 6 cases (8.8%) were correctly diagnosed; 54 cases (79.4%) were missed; 8 cases (11.8%) were misdiagnosed, including 7 cases (10.3%) of bladder tumor and 1 case (1.5%) of retroperitoneal giant mass.Conclusions:Pelvic lipomatosis has characteristic sonographic features.When urinary tract obstruction and bladder wall thickening are observed, pelvic lipomatosis should be considered. Bladder shape and existence of increasing fat-like hyperecho in the pelvis should be further scanned to reduce the misdiagnosis rate of pelvic lipomatosis.
6. Effect of goal orientation combined with plan-do-check-act cycle improvement on the professional teaching of critical care medicine
Mingyuan MA ; Zhenhong QI ; Menghua DENG ; Yunhai ZHANG ; Haobo JIANG
Chinese Journal of Medical Education Research 2019;18(10):1033-1037
Objective:
To investigate the promotional effect of the new teaching method of goal orientation combined with plan
7.PlaD: A Transcriptomics Database for Plant Defense Responses to Pathogens, Providing New Insights into Plant Immune System.
Huan QI ; Zhenhong JIANG ; Kang ZHANG ; Shiping YANG ; Fei HE ; Ziding ZHANG
Genomics, Proteomics & Bioinformatics 2018;16(4):283-293
High-throughput transcriptomics technologies have been widely used to study plant transcriptional reprogramming during the process of plant defense responses, and a large quantity of gene expression data have been accumulated in public repositories. However, utilization of these data is often hampered by the lack of standard metadata annotation. In this study, we curated 2444 public pathogenesis-related gene expression samples from the model plant Arabidopsis and three major crops (maize, rice, and wheat). We organized the data into a user-friendly database termed as PlaD. Currently, PlaD contains three key features. First, it provides large-scale curated data related to plant defense responses, including gene expression and gene functional annotation data. Second, it provides the visualization of condition-specific expression profiles. Third, it allows users to search co-regulated genes under the infections of various pathogens. Using PlaD, we conducted a large-scale transcriptome analysis to explore the global landscape of gene expression in the curated data. We found that only a small fraction of genes were differentially expressed under multiple conditions, which might be explained by their tendency of having more network connections and shorter network distances in gene networks. Collectively, we hope that PlaD can serve as an important and comprehensive knowledgebase to the community of plant sciences, providing insightful clues to better understand the molecular mechanisms underlying plant immune responses. PlaD is freely available at http://systbio.cau.edu.cn/plad/index.php or http://zzdlab.com/plad/index.php.
Arabidopsis
;
genetics
;
Databases, Genetic
;
Gene Expression Profiling
;
Gene Expression Regulation, Plant
;
Gene Regulatory Networks
;
Genes, Plant
;
Host-Pathogen Interactions
;
genetics
;
Oryza
;
genetics
;
Plant Immunity
;
genetics
;
Plants
;
genetics
;
microbiology
;
Transcriptome
;
genetics
;
Triticum
;
genetics
;
User-Computer Interface
;
Zea mays
;
genetics
8.Preparation Technology Optimization of Hongteng Decoction Hollow Suppositories by Orthogonal Test
Defeng LUO ; Fangxiang ZHANG ; Fen WANG ; Jingjing QI ; Zhenhong ZOU
China Pharmacist 2016;19(5):1006-1008
Objective:To establish an optimum preparation process for Hongteng decoction hollow suppositories. Methods:An orthogonal design was performed to screen the proportion of drug and base(A),the temperature of mold filling with drug and base(B)and stripping time(C),and the appearance and melting time were used as the indices ,the best preparation technology of the hollow suppositories was optimized. Results:The optimum preparation technology of the hollow suppositories was as follows:the proportion of drug and base was 1 ∶2,the filling temperature was 40℃,and the stripping time was 30 min. Conclusion:The optimum preparation technology of Hongteng decoction hollow suppositories is simple and feasible.
9.The effect of Xuebijing injection on transfusion and inflammatory factors in patients with traumatic coagulopathy
Mingyuan MA ; Haobo JIANG ; Yunhai ZHANG ; Menghua DENG ; Na YU ; Zhenhong QI
The Journal of Practical Medicine 2015;(20):3415-3418
Objective To study the effect of Xuebijing injection on transfusion and systemic inflammation in traumatic coagulopathy patients. Methods Seventy-nine patients were randomly divided into Xuebijing Group (36 cases) and Control Group (43 cases). Xuebijing group received Xuebijing injection in addition to the regular treatment received by control group. Levels of TNF-α, IL-6, IL-8 and transfusion amount between two groups were compared. Results Coagulation abnormality was almost corrected in all patients after treatment. In Xuebijing Group, transfusion of RBC, FFP and cryoprecipitate were significantly less than that in control group (P<0.05). At 72 h after admission, TNFα, IL-6 and IL-8 were significantly lower in Xuebijing Group (P < 0.05). Conclusion Xuebijing injection could reduce transfusion in traumatic coagulopathy patients , possibly resulting from its antagonism against systemic inflammation.
10.Application of Xuebijing injection in severe craniocerebral injury patients with coagulation disturbance
Haobo JIANG ; Mingyuan MA ; Yunhai ZHANG ; Menghua DENG ; Na YU ; Zhenhong QI
Chinese Journal of Neuromedicine 2015;14(9):937-940
Objective To study the therapeutic effect of Xuebijing injection in severe craniocerebral injury patients with coagulation disturbance.Methods Sixty-five patients were randomly divided into Xuebijing treatment group (n=35) and control group (n=30).They all received regular treatment,while Xuebijing treatment group received Xuebijing injection additionally (0.9% sodium chloride injection 100 mL adding 30 mL Xuebijing twice daily for a consecutive 10 d).Prothrombin time (PT),active partial thromboplastin time (APTT),levels of blood platelet (PLT),d-dimer (DD),tumor necrosis factor α (TNF-α),interldeukin (IL)-6 and IL-8,and Glasgow coma scale (GCS) scores at different time points,progressive intracranial hemorrhage (PIH) rate within 72 h,survival rate of 28 d were compared between two groups.Results Coagulation in all patients after treatment was significantly improved as compared with that before treatment (P<0.05).At 72 h after treatment,the PT,APTT,and levels of DD and PLT in Xuebijing treatment group were significantly improved as compared with those in the control group (P<0.05);levels ofTNF-α,IL-6 and IL-8 at 72 h after treatment in the treatment group ([1.41±0.32] ng/L,[80.4±25.1] ng/L and [5.17±0.59] ng/L) were significantly lower than those in the control group ([1.74±0.30] ng/L,[96.6±23.4] ng/L and [8.32±0.72] ng/L],P<0.05).The PIH rate within 72 h in the treatment group (31.4%) was significantly lower than that in the control group (46.7%,P<0.05).Conclusion Xuebijing injection could improve the abnormal coagulation and lower the PIH rate in severe craniocerebral injury patients with coagulation disturbance,possibly because Xuebijing injection could ameliorate inflammation.

Result Analysis
Print
Save
E-mail